Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Fully equipped labs with 75-member team set-up and made operational in <100 days
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Science communication brings behavioural changes
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Subscribe To Our Newsletter & Stay Updated
